| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/24/2013 | CN103212078A Combinations comprising mglur modulators for the treatment of parkinson's disease |
| 07/24/2013 | CN103212035A Medicament for treating incoordination between liver and spleen and imbalance between heart-yang and kidney-yin |
| 07/24/2013 | CN103212028A Traditional Chinese medicine for treating schizophrenia |
| 07/24/2013 | CN103212025A Traditional Chinese medicine preparation for treating postherpetic neuralgia |
| 07/24/2013 | CN103212019A Chinese materia medica preparation for treating depression |
| 07/24/2013 | CN103212011A Bone-strengthening pain-relieving paste and preparation method thereof |
| 07/24/2013 | CN103212009A Medicine for treating cardiovascular and cerebtovascular diseases |
| 07/24/2013 | CN103211982A Medicament for treating prosopalgia |
| 07/24/2013 | CN103211979A New use of dendrobium officinale kimura et migo in diabetic complication prevention and treatment |
| 07/24/2013 | CN103211962A Chinese medicinal composition for treating anhypnia |
| 07/24/2013 | CN103211952A Traditional Chinese medicine composition used for treating edema |
| 07/24/2013 | CN103211934A Medicine for treating senile dementia and preparation method thereof |
| 07/24/2013 | CN103211918A Antler tray wine for invigorating the kidney and strengthening Yang and preparation method thereof |
| 07/24/2013 | CN103211917A Antler plate wine and preparation method thereof |
| 07/24/2013 | CN103211916A Antler disc wine for regulating menstruation, nourishing blood and supplementing calcium, and preparation method thereof |
| 07/24/2013 | CN103211914A Chinese medicinal formula beneficial to improving sleep quality |
| 07/24/2013 | CN103211910A Detoxifying and lipid reducing capsules and preparation method thereof |
| 07/24/2013 | CN103211907A Siwu decoction formulated particles, and preparation method and detection method thereof |
| 07/24/2013 | CN103211900A Traditional Chinese medicine formula for treatment of hyperosteogeny and sciatica |
| 07/24/2013 | CN103211892A Chinese medicinal composition for treating insomnia |
| 07/24/2013 | CN103211847A Prescription for treating dizziness |
| 07/24/2013 | CN103211841A Prescription for treating epilepsy |
| 07/24/2013 | CN103211832A Medicine composition containing myricetrin or/and myricetin and application of medicine composition in preparation of medicine used for treating Parkinson |
| 07/24/2013 | CN103211824A Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases |
| 07/24/2013 | CN103211823A Use of 20(S)-protopanoxadiol derivatives and 20(S)-protopanaxatriol derivatives in preparation of antidepressant medicines |
| 07/24/2013 | CN103211808A Application of salvianolic acid A composition in preparing medicines used for inhibiting brain tissue neuron damage or death |
| 07/24/2013 | CN103211807A Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions |
| 07/24/2013 | CN103211803A Application of tamoxifen in treatment of early brain injury after subarachnoid hemorrhage |
| 07/24/2013 | CN103211801A Film agent quickly dissolved in oral cavity and preparation method thereof |
| 07/24/2013 | CN103211794A Quetiapine fumarate film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211792A Metoprolol fumarate film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211791A Venlafaxine hydrochloride film-controlled slow-release pellet capsule |
| 07/24/2013 | CN103211777A Pharmaceutic preparation of duloxetine hydrochloride and preparation method thereof |
| 07/24/2013 | CN103211776A Medical composition of orally disintegrating tablet containing blonanserin and preparation method thereof |
| 07/24/2013 | CN103211766A Methods for dosing an orally active 1,2,4-oxadiazole for nonsense mutation suppression therapy |
| 07/24/2013 | CN103211757A Edaravone injection and preparation method thereof |
| 07/24/2013 | CN103211751A Medical composition containing vilazodone and preparation method thereof |
| 07/24/2013 | CN103211055A Pabular health tea electuary for nourishing brain |
| 07/24/2013 | CN102727858B Medical composition for treating headaches and migraine, preparation method and application thereof |
| 07/24/2013 | CN102631467B Honglong antalgic medicinal composition, and preparation method and application thereof |
| 07/24/2013 | CN102614407B Chinese medicinal composition for treating postpartum depression |
| 07/24/2013 | CN102552713B Medicine for treating epilepsy and preparation method thereof |
| 07/24/2013 | CN102552601B Medicament for treating schizophrenia |
| 07/24/2013 | CN102552423B Medicinal composition for treating migraine |
| 07/24/2013 | CN102552125B Injection composition containing oxiracetam and preparation method and application thereof |
| 07/24/2013 | CN102531966B Novel crystal form D of Retigabine and preparation method thereof |
| 07/24/2013 | CN102370866B Medicinal composition for preventing and treating diabetic nerve pathology |
| 07/24/2013 | CN102362893B Ganoderma lucidum-chrysanthemum capsule for improving sleep and preparation method thereof |
| 07/24/2013 | CN102321204B Selenium resin load, and intermediate, preparation method and application thereof |
| 07/24/2013 | CN102228457B Pharmaceutical composition for treating diabetes and complication thereof |
| 07/24/2013 | CN102120773B Dual specificity antibodies and methods of making and using |
| 07/24/2013 | CN101848712B Treatment of progressive neurodegenerative disease with ibudilast |
| 07/24/2013 | CN101730684B Sulfonyl-quinoline derivatives |
| 07/24/2013 | CN101698051B Application of traditional Chinese medicine composite in preparing medicine treating climacteric syndrome |
| 07/24/2013 | CN101668760B Aminopyrimidines useful as inhibitors of protein kinases |
| 07/24/2013 | CN101663302B Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 07/24/2013 | CN101506157B Co-crystals of pyrrolidinones |
| 07/24/2013 | CN101326171B Novel dual peptidase inhibitors as prodrugs for the therapy of inflammatory and other disorders |
| 07/23/2013 | US8492540 1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 07/23/2013 | US8492418 Method of treating schizophrenia prodrome |
| 07/23/2013 | US8492416 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/23/2013 | US8492389 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/23/2013 | US8492376 Heteroaryl-cyclohexyl-tetraazabenzo[e]azulenes |
| 07/23/2013 | US8492375 1-benzoyl substituted diazepine derivatives as selective histamine H3 receptor agonists |
| 07/23/2013 | US8492341 Amyloid-β binding peptides |
| 07/23/2013 | US8492340 Methods of treating depression and other related diseases |
| 07/23/2013 | US8492145 Process for producing nerve cells |
| 07/23/2013 | US8491935 Modified release formulations containing drug-ion exchange resin complexes |
| 07/23/2013 | US8491890 Methods and compositions for inhibiting diseases of the central nervous system |
| 07/23/2013 | CA2583967C 6-amino(aza)indane compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 07/23/2013 | CA2566090C Substituted n-aryl benzamides and related compounds for treatment of amyloid diseases and synucleinopathies |
| 07/23/2013 | CA2544574C Stable vitamin b6 derivative |
| 07/23/2013 | CA2542695C Substituted benzylaminoalkylene heterocycles |
| 07/23/2013 | CA2534675C Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 07/23/2013 | CA2377357C Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/23/2013 | CA2357950C Therapeutic phosphodiesterase inhibitors |
| 07/18/2013 | WO2013106528A1 Bivalent ligands for the treatment of neurological disorders |
| 07/18/2013 | WO2013106349A1 Use of the aminoalkylindole jwh-073-m4 and related compounds as neutral cb1 recptor antagonists for the treatment of alcoholism, drug abuse, obesity, and obesity-related diseases |
| 07/18/2013 | WO2013106084A1 Methods and drug products for treating alzheimer's disease |
| 07/18/2013 | WO2013105608A1 P2x4 receptor antagonist |
| 07/18/2013 | WO2013105092A1 Fixed dose combination therapy of parkinson's disease |
| 07/18/2013 | WO2013104933A1 3,3-diphenyl-n-(1-phenylethyl) propan-1 -amine : as a new selective ligand of the sigma-1 receptors, with anti-apoptotic (cytoprotective) properties and prototypical anticancer activity |
| 07/18/2013 | WO2013104591A1 Heterocyclic derivatives as trace amine associated receptors (taars) |
| 07/18/2013 | WO2013104575A1 Thienopyrimidine compounds |
| 07/18/2013 | WO2013104539A1 Nucleic acids specifically binding cgrp |
| 07/18/2013 | WO2013070852A3 Compounds and compositions used to epigenetically transform cells and methods related thereto |
| 07/18/2013 | WO2013070117A3 Fluorine-containing 5-[2-(pyrid-3-yl)-ethyl]-2,3,4-tetrahydro-1н-pyrido[4,3-b]indoles as agents for reducing uncontrolled protein aggregation |
| 07/18/2013 | WO2013048949A3 Selective nr2b antagonists |
| 07/18/2013 | US20130184325 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
| 07/18/2013 | US20130183386 Process for obtaining a rabbit skin comprising biological active substances |
| 07/18/2013 | US20130181107 Furnace mount and method of installation |
| 07/18/2013 | CA2860952A1 Fixed dose combination therapy of parkinson's disease |
| 07/18/2013 | CA2856204A1 Heterocyclic derivatives as trace amine associated receptors (taars) |
| 07/17/2013 | EP2615086A1 2,4-Diaminoquinazolines for the treatment of spinal muscular atrophy |
| 07/17/2013 | EP2614824A1 Therapeutic agent for pain |
| 07/17/2013 | EP2614821A1 Pharmaceutical composition for treating anxiety disorder, containing n-acetyl-l-cysteine or derivative thereof |
| 07/17/2013 | EP2614076A1 Modified relaxin polypeptides |
| 07/17/2013 | EP2614075A1 Single chain relaxin polypeptides |
| 07/17/2013 | EP2614061A1 Quinoline and quinoxaline derivatives as kinase inhibitors |
| 07/17/2013 | EP2614060A2 2-(r2-thio)-10-[3-(4-r1-piperazin-1-yl)propyl]-10h-phenothiazine for treating a beta-amyloidopathy or an alpha-synucleopathy, and method for the diagnosis or prediagnosis thereof |